-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Disc Medicine (NASDAQ:IRON) stock moved upwards by 50.4% to $85.51 during Monday's pre-market session. The company's market cap stands at $2.1 billion.
  • DataMEDS AI (NASDAQ:MEDS) shares moved upwards by 19.77% to $3.15. The market value of their outstanding shares is at $9.1 million.
  • Virax Biolabs Group (NASDAQ:VRAX) stock moved upwards by 17.24% to $1.7. The company's market cap stands at $1.2 million.
  • Alaunos Therapeutics (NASDAQ:TCRT) stock rose 17.11% to $3.08. The company's market cap stands at $5.5 million.
  • Akari Therapeutics (NASDAQ:AKTX) stock rose 13.01% to $9.24. The market value of their outstanding shares is at $20.2 million.
  • Rapport Therapeutics (NASDAQ:RAPP) shares rose 12.44% to $31.0. The company's market cap stands at $1.4 billion.

Losers

  • EyePoint (NASDAQ:EYPT) shares decreased by 80.0% to $0.6 during Monday's pre-market session. The company's market cap stands at $270.7 million.
  • CDT Equity (NASDAQ:CDT) stock declined by 12.81% to $0.2.
  • Actuate Therapeutics (NASDAQ:ACTU) shares decreased by 12.32% to $0.53. The company's market cap stands at $12.0 million.
  • Sera Prognostics (NASDAQ:SERA) stock fell 10.2% to $1.85. The company's market cap stands at $80.0 million.
  • Matinas BioPharma Hldgs (AMEX:MTNB) stock decreased by 9.29% to $2.15. The market value of their outstanding shares is at $35.5 million.
  • Estrella Immunopharma (NASDAQ:ESLA) stock decreased by 8.45% to $0.39. The market value of their outstanding shares is at $23.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending